Ara
Toplam kayıt 6, listelenen: 1-6
How telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review
(MDPI, 2022)
Background and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related ...
Headache onset after vaccination against SARS-CoV-2: A systematic literature review and meta-analysis
(BMC, 2022)
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced ...
From asymptomatic to critical illness: Decoding various clinical stages of COVID-19
(The Scientific and Technological Research Council of Turkey, 2021)
The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range ...
Covid-19: Pathogenesis, genetic polymorphism, clinical features and laboratory findings
(TUBITAK Scientific & Technological Research Council of Turkey, 2020)
COVID-19 caused by a novel agent SARS-CoV-2 progressed to a pandemic condition and resulted in a major public health concern worldwide, leading to social and economic issues at the same time. The pathogenesis of COVID-19 ...
E-leadership and teleworking in times of COVID-19 and beyond: What we know and where do we go
(Frontiers Media S.A., 2020)
Suddenly, COVID-19 has changed the world and the way people work. Companies had to accelerate something they knew was imminent in the future, but not immediate and extremely humongous. This situation poses a huge challenge ...
Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic
(MDPI, 2021)
Background. Tocilizumab is an anti-IL-6 therapy widely adopted in the management of the so-called "cytokine storm" related to SARS-CoV-2 virus infection, but its effectiveness, use in relation to concomitant corticosteroid ...